ArticleMolecular oncology2015

Combination of novel HER2-targeting antibody 1E11 with trastuzumab shows synergistic antitumor activity in HER2-positive gastric cancer.

Bong-Kook Ko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.